繁體中文
不翻译
简体中文
English
繁體中文
日本語
한국어
切換到窄版

WK綜合論壇, WK综合论坛

 找回密碼
 立即注册
樓主: wk007

鄉下的妹子太便宜,一次四個都要了[12P]

[複製鏈接]
發表於 2014-4-15 16:21:37 | 顯示全部樓層
good good support
發表於 2014-8-27 20:16:40 | 顯示全部樓層
好图,谢谢分享。
發表於 2015-8-20 20:13:55 | 顯示全部樓層
大家好心情
發表於 2019-11-30 20:45:29 | 顯示全部樓層
果您要查看本帖隱藏內容請
發表於 2022-1-27 10:28:29 | 顯示全部樓層
真的很不错
發表於 2025-1-4 03:09:28 | 顯示全部樓層
RESPONSE OF MICROPENIS TO TOPICAL TESTOSTERONE AND
) A& v- N. i6 M; x% V1 NGONADOTROPIN
+ P1 W. [5 l. [RICHARD C. KLUGO* AND JOSEPH C. CERNY
3 r7 Y+ }) C% @& B/ d3 j9 pFrom the Division of Urology, Henry Ford Hospital, Detroit, Michigan* B' i6 D% F4 b/ Z' K' H. S. F
ABSTRACT
% D+ b2 q! m+ Q7 C. x" _Five patients were treated with gonadotropin and topical testosterone for micropenis associated
) f9 R' l4 t+ q! b) {/ Lwith hypothalamic hypogonadotropic hypogonadism. All patients received 1,000 units of gonado-
' r# U$ o3 Q  y0 a% I/ Mtropin weekly for 3 weeks, with a 6-week interval followed by 10 per cent topical testosterone: u# B3 h7 O$ o  {1 m* m6 r
cream twice daily for 3 weeks. Serum testosterone levels were measured and remained equivalent, X' e; V5 T7 F' q7 B0 f' x  n9 B
for both modes of therapy. Average penile growth response with gonadotropin was 14.3 per cent$ S( j3 V+ E, c
increase in length and 5.0 per cent increase of girth. Topical testosterone produced an average
4 C$ u: d; }$ A* r$ \increase of 60 per cent in penile length and 52. 9 per cent in girth. The greatest growth response
: f! a9 {  S* u; \occurred in prepuberal male subjects with a minimal response in postpuberal male subjects. This
6 k! S& Z% J% u& L* r8 q, V) Istudy suggests that 10 per cent topical testosterone cream twice daily will produce effective penile
6 @: W2 K0 J, C" qgrowth. The response appears to be greater in younger children, which is consistent with previ-! g# F+ u5 x. _3 c6 Z3 B1 L
ously published studies of age-related 5 reductase activity." b3 t2 ?- `9 k% s' {' ]* @
Children with microphallus regardless of its etiology will
# Y2 n  B! W% u+ Prequire augmentation or consideration for alteration of exter-
- `5 Z, W( X0 l4 f/ l# S- C8 P& X1 xnal genitalia. In many instances urethroplasty for hypo-
6 _' A+ N4 j& k& K* @spadias is easier with previous stimulation of phallic growth.- ^6 ~/ Y8 x: ]5 m0 k: ]5 S
The use of testosterone administered parenterally or topically
7 j. p7 a# ~# e  L6 B. hhas produced effective phallic growth. 1- 3 The mechanism of$ E: P# R5 X- j% y, c5 `' P; w
response has been considered as local or systemic. With this
' i$ d  s" Q2 _in mind we studied 5 children with microphallus for response/ ~) K  I' ]0 s1 `. h" U5 R
to gonadotropin and to topical testosterone independently., e2 f# u% F/ B, H) h6 g
MATERIALS AND METHODS* o) A; X- U' _4 M5 {
Five 46 XY male subjects between 3 and 17 years old were
, g) P5 W7 }0 Q  X- l! ?evaluated for serum testosterone levels and hypothalamic) @- L& p% C% b8 `# ^
function. Of these 5 boys 2 were considered to have Kallmann's& N3 D0 Q0 f) O. }9 @0 R; M
syndrome, 1 Prader-Willi syndrome and 2 idiopathic hypotha-0 t- U. j) A3 q$ U
lamic deficiency. After evaluation of response to luteinizing
. r2 a0 ]% f( ]2 A( @hormone-releasing hormone these patients were treated with, R1 k) ^) j/ L
1,000 units of gonadotropin weekly for 3 weeks. Six weeks- I1 [3 E' `. A0 s9 J
after completion of gonadotropin therapy 10 per cent topical
6 I" J. ]" G0 s# D' stestosterone was applied to the phallus twice daily for 3 weeks.
$ N8 ^* ]) Q) m! Z) }" u1 S) d3 GSerum testosterone, luteinizing hormone and follicle-stimulat-! s# {/ S9 ?( C! S& Y# _
ing hormone were monitored before, during and after comple-
/ _4 N) w3 K/ r8 Jtion of each phase of therapy. Penile stretch length was
5 ?1 G. p' e  \' |! }' Z3 bobtained by measuring from the symphysis pubis to the tip of
: u$ k& g8 @" ^2 M; m$ Gthe glans. Penile circumferential (girth) measurements were- M$ V" C) v* T" D  U5 p
obtained using an orthopedic digital measuring device (see) Y! i* \6 n0 u( h1 p( z
figure).$ [  N5 q6 D  n5 p5 v
RESULTS
- f3 z+ J/ D( _6 BSerum testosterone increased moderately to levels between) A. S# N% B$ O; M) ]) {3 x: u
50 and 86 ng./dl. with gonadotropin stimulation. Serum testos-8 c7 j$ i- t/ V4 c% ]6 v: N
terone levels with topical testosterone remained near pre-
; \9 [" H( I8 P& @; l7 mtreatment levels (35 ng./dl.) or were elevated to similar levels2 B0 M& _( M! K  a- k6 e1 s
developed after gonadotropin therapy (96 ng./dl.). Higher
; w* E. _# U, [' ]7 ^  Y$ jserum levels were noted in older patients (12 and 17 years old),. x. j% B- V5 \2 p) `! F& q; f
while lower levels persisted in younger patients (4, 8, and 105 s5 v6 Y; ~* h+ |6 r" ~, u
years old) (see table). Despite absence of profound alterations" H% \2 m. @+ O5 d6 V6 b
of serum testosterone the topical therapy provided a greater% q$ p- _) g( k4 I, ?- I& f
Accepted for publication July 1, 1977. ·
% a  z# E5 y9 W, pRead at annual meeting of American Urological Association,1 H. n$ \7 C5 a% t: B
Chicago, Illinois, April 24-28, 1977.
) Z! P" u8 Y- ]# P6 o5 p' a* Requests for reprints: Division of Urology, Henry Ford Hospital,
: `5 r) R% a3 c: [. |; o: X2799 W. Grand Blvd., Detroit, Michigan 48202.9 u1 H9 S9 W; w( c
improvement in phallic growth compared to gonadotropin.
8 z* a' N2 X1 r) f. k9 ^1 rAverage phallic growth with gonadotropin was 14.3 per cent! |% U, r$ G  b! B% [" \! o0 b
increase in length and 5.0 per cent increase of girth. Topical
$ q! D9 N+ {: w# n  c7 [: etestosterone produced a 60.0 per cent increase of phallic length
% K$ ~: w+ X8 H& c6 ]3 @9 E& Wand 52.9 per cent increase of girth (circumference). The3 A. G! B! {9 ~1 i/ P
response to topical testosterone was greatest in children be-0 P7 z! u! L6 Q) Y. R5 m
tween 4 and 8 years old, with a gradual decrease to age 17
7 R' l. D! k1 r) b! Cyears (see table).% l8 T% P$ F, u1 b+ p  U" P5 d8 l
DISCUSSION; Z' }8 d( ~- j1 y8 v+ K
Topical testosterone has been used effectively by other) J: f( S5 M8 M5 H0 B" C* x. n
clinicians but its mode of action remains controversial. Im-& A: G0 O1 E/ I7 J% |' N
mergut and associates reported an excellent growth response  ^1 _2 h7 p/ C0 o9 @' N
to topical testosterone with low levels of serum testosterone,
: N% Q  E/ |. P0 M8 z( k- _0 ?suggesting a local effect.1 Others have obtained growth re-; K2 A# Z- e) u! J+ ^" {: M
sponse with high. levels of serum testosterone after topical; y* h) r& w# w% r- u
administration, suggesting a systemic response. 3 The use of# i- g7 e6 {" `, l* I! W
gonadotropin to obtain levels of serum testosterone compara-
( |& t# N. Q# F! q+ J( z6 o- sble to levels obtained with topical testosterone would seem to0 q* A2 H, L/ A& o& d3 _; G
provide a means to compare the relative effectiveness of
) V4 U! Z2 O" I9 t& i+ N# t  \topical testosterone to systemic testosterone effect. It cer-+ e0 G7 J: ^1 I3 W2 y  i  v! J
tainly has been established that gonadotropin as well as par-
# i, o: }) X$ }7 ~" ]enteral testosterone administration will produce genital
) u' k7 L' h1 q( V" Qgrowth. Our report shows that the growth of the phallus was1 ^1 M& {7 |3 d
significantly greater with topical applications than with go-
; B. T1 j8 i5 G" P( \+ a( T8 Nnadotropin, particularly in children less than 10 years old.) ?: o2 _  ?' i& l
The levels of serum testosterone remained similar or lower
0 z' Z% I0 S; Z4 kthan with gonadotropin during therapy, suggesting that topi-4 M+ p' z2 V3 R! [* j) f2 L& O
cal application produces genital growth by its local effect as1 O3 ]1 o% A" H' N" f6 J5 z
well as its systemic effect.
" T# V# P, @; g4 [& _* UReview of our patients and their growth response related to
0 Q) V. u! P3 w( Q" T$ m! Rage shows a greater growth response at an earlier age. This is
# l) l+ {4 z$ Qconsistent with the findings of Wilson and Walker, who
) r: }& b4 ^2 j/ E8 yreported an increased conversion of testosterone to dihydrotes-! Q) f- @, H; w
tosterone in the foreskin of neonates and infants.4 This activ-
0 B2 ~2 u4 L: C% Qity gradually decreases with age until puberty when it ap-
, \  h( m4 k( g2 {- H: K7 kproaches the same level of activity as peripheral skin. It may
6 L5 l: j- M& [5 Q2 ]# Iwell be that absorption of testosterone is less when applied at
  S0 `' U8 q: v: Zan earlier age as suggested by lower serum levels in children( v' y) a! ]% ?1 H3 D2 G. g
less than 10 years old. This fact may be explained by the7 L- R' C; G/ Q3 J& B4 w
greater ability of phallic skin to convert testosterone to dihy-
1 [/ M8 F& s* O7 w7 |9 ~drotestosterone at this age. Conversely, serum levels in older. y: n6 k& h2 a7 k
patients were higher, possibly because of decreased local
  b: A, [5 ]9 o' \; m6 R# {. i667
8 s9 T3 K5 Z, c* ?668 KLUGO AND CERNY
% L* ^/ K. D+ E/ Y" WPt. Age2 h% o, l. e+ J/ E! f
(yrs.)
$ O0 o- i2 H8 [7 FSerum Testosterone Phallus (cm.) Change Length' R& D/ J2 f! e: ^% L
(ng./dl.) Girth x Length (%). o+ _5 t4 x, \$ M
4
$ ?4 B9 V. b7 J7 Z( u7 T( ]+ x8
7 {. w/ ^" I( L  z0 [/ Z; ]3 [10( E! m7 V; o3 q# H7 u' A
12. j) j# F2 U9 }+ Z) l
179 o: B( M$ Q$ I/ E2 d+ I, k0 w% w
Gonadotropin
, N& j' y5 i6 Z71.6 2.0 X 3 16.6/ h' N2 I2 R. L/ y5 R; M* y
50.4 4.0 X 5.0 20.0
  ]3 I. d  s$ X& e) {$ B22.0 4.5 X 4.0 25.0# A4 }* a' B2 I
84.6 4.0 X 4.5 11.1
8 ~3 I7 H5 ~# u* z+ Q85.9 4.5 X 5.5 9.0
5 P; T+ v" Y, z% y9 S9 GAv. 14.3
$ F, C) P- g! w: H. l0 E3 S4
# u  g1 W7 Q  B84 h3 i/ Z# U$ v' n. V  O
10
* g6 N0 M. ~& i5 t5 c! T" O12. ~5 m9 j- F( f& M3 |2 ^2 A) X% Z
17
# ^" V$ }7 _- d! q( rTopical testosterone
' E! N' q, W/ U1 v" @& c) n. i34.6 4.5 X 6.5 85
0 L6 ~# u/ x4 T( H; e38.8 6.0 X 8.5 70
: R8 P; F! W3 j. t( l40.0 6.0 X 6.5 62.5
2 l: v. G+ }1 H93.6 6.0 X 7.0 55.57 e3 @0 G/ U% L3 U- z
95.0 6.5 X 7.0 27.2
, j1 |4 R/ T7 e( I; P5 o4 j% UAv. 60.0
4 r: s2 N1 l. i' Wavailable testosterone. Again, emphasis should be placed on
7 n0 T$ Z8 B8 l9 O; Bearly therapy when lower levels of testosterone appear to3 L; J8 B3 t/ S, Z, }0 ^- E! I: ~
provide the best responses. The earlier therapy is instituted; a- R# I; \3 p
the more likely there will be an excellent response with low( O& N6 T. U- h% U( E; P
serum levels. Response occurs throughout adolescence as
* _% ~3 [5 H" }& ^- bnoted in nomograms of phallic growth. 7 The actual response
% x3 f* J, J- t7 J' I$ j1 Xto a given serum level of testosterone is much greater at birth
6 ~) k: @: `: z  g# b7 I" |and gradually decreases as boys reach puberty. This is most
+ u$ q6 x, o; y$ W1 Zlikely related to the conversion of testosterone to dihydrotes-
  K7 R. ?$ ~) W: W) a8 T/ K  Utosterone and correlates well with the studies of testosterone
1 y( r5 ?2 W) Oconversion in foreskin at various ages.
" y! B, ?: G' w0 X  `The question arises regarding early treatment as to whether/ g; F% b- d( g2 J9 C( w
one might sacrifice ultimate potential growth as with acceler-
' p! a9 V2 k+ d7 g" j7 @ated bone growth. The situation appears quite the reverse6 i- Q2 G% W! E
with phallic response. If the early growth period is not used
7 P: P$ S' Z' S8 Hwhen 5a reductase activity is greatest then potential growth
7 g! {6 ?8 q! F, n. O$ `may be lost. We have not observed any regression of growth% f0 `# [2 G3 @+ l5 v, b# f, ], I
attained with topical or gonadotropin therapy. It may well# B9 }( M0 y5 W/ U; M0 R+ h
be that some patients will show little or no response to any
  p' d, V2 N8 |; Lform of therapy. This would suggest a defect in the ability to
5 n8 V/ B4 f' n1 B% Vconvert testosterone to dihydrotestosterone and indicate that
% ~6 {* P* ^' E, t& i0 q, L9 F1 }phallic and peripheral skin, and subcutaneous tissue should; `8 \( O, a+ b1 s! B
be compared for 5a reductase activity.
* ?2 z( S! H* OA, loop enlarges to measure penile girth in millimeters. B,* o# L0 _# O% _' ]! _2 K
example of penile girth computed easily and accurately.
. w/ f* E2 k; C1 Hconversion of testosterone to dihydrotestosterone. It is in this8 f7 X( _0 B" I* A0 @3 U
older group that others have noted high levels of serum3 V/ N2 ]* v0 \/ h+ X2 t. G
testosterone with topical application. It would also appear
( Q$ D9 {) v, U) }9 \' R7 D7 h7 v# D1 Pthat phallic response during puberty is related directly to the7 w/ x/ f4 |* S9 U* R
serum testosterone level. There also is other evidence of local5 E" n( N. l  a' j2 |4 G
response to testosterone with hair growth and with spermato-8 f+ t* x  x( `: E$ R7 J
genesis. 5• 6' i6 ~8 c: P' A- E+ K5 D
Administration of larger doses of gonadotropin or systemic8 r; ?. ]3 v4 c) E7 r$ j
testosterone, as well as topical applications that produce2 |5 x( f9 G! z
higher levels of serum testosterone (150 to 900 ng./dl.), will
7 {1 W5 P, h1 G! d" W$ A5 |: v: ]also produce phallic growth but risks accelerated skeletal
- o/ D! p& W6 _9 E+ Xmaturation even after stopping treatment. It would appear* n8 r, T, Q, v* ~
that this may be avoided by topical applications of testosterone3 Q( C9 @) a2 Z& _
and monitoring of serum testosterone. Even with this control
3 n6 R4 z  x2 T. i7 `- Cthe duration of our therapy did not exceed 3 weeks at any! I2 E+ }" S$ m: H
time. It is apparent that the prepuberal male subject may
$ T! {/ e: U4 v5 i) `  ksuffer accelerated bone growth with testosterone levels near/ ]0 M0 T( ~0 z' H: c' H1 p) ]
200 ng./dl. When skeletal maturation is complete the level of
$ h& k$ w; n! Sserum testosterone can be maintained in the 700 to 1,300 ng./
+ @& j/ w; k$ ^  P3 g6 L9 @- Qdl. range to stimulate phallic growth and secondary sexual& i1 V* A5 s3 X. d; e
changes. Therefore, after skeletal maturation parenteral tes-
& f4 U" _5 t9 l$ k; itosterone may be used to advantage. Before skeletal matura-
  n. {: q5 C4 W5 z" _" C0 f' q! Dtion care must be taken to avoid maintaining levels of serum( d; l  y( Y' f8 ^
testosterone more than 100 ng./dl. Low-dose gonadotropin
! M& ^0 t4 Y" y- F9 t1 odepends upon intrinsic testicular activity and may require& R" |9 {) }- Y) f+ _' E  n5 x- [
prolonged administration for any response./ ~# L* ]" d/ V. `1 H7 w
Alternately, topical testosterone does not depend upon tes-; P2 L! O& ?3 L
ticular function and may provide a more constant level of
! J) U, Q) |: K1 w1 {1 ~REFERENCES/ V+ Q: b  W$ j5 Q) |& V
1. Immergut, M., Boldus, R., Yannone, E., Bunge, R. and Flocks," i! `/ I& F: E; m, f
R.: The local application of testosterone cream to the prepub-# f# q3 z: k4 n$ F& B# [1 z
ertal phallus. J. Urol., 105: 905, 1971.
0 v* }, G  c( G2. Guthrie, R. D., Smith, D. W. and Graham, C. B.: Testosterone" X3 u1 o% e% p+ {' r) N$ a4 r
treatment for micropenis during early childhood. J. Pediat.,3 E' V8 [4 S4 @+ p! q* q) w
83: 247, 1973.9 J! B! s: B, s. ^+ k
3. Jacobs, S. C., Kaplan, G. W. and Gittes, R. F.: Topical testoster-
2 b7 k$ R% e0 N5 F% Z& j2 I( Yone therapy for penile growth. Urology, 6: 708, 1975.
7 i4 a) F' }7 A0 S9 J4. Wilson, J. D. and Walker, J. D.: The conversion of testosterone8 i! d+ Y; k$ C% h/ w8 e
to 5 alpha-androstan-17 beta-01-3-one (dihydrotestosterone) by
  [) P/ F% M  nskin slices of man. J. Clin. Invest., 48: 371, 1969.
  z! t/ y! v& Q7 Q$ _5. Papa, C. M. and Klingman, A. M.: Stimulation of hair growth" G* s( T  w. _- F
by topical application of androgens. J.A.M.A., 191: 521, 1965.
# _1 M0 v2 m$ O  h  r6. Gittes, R. F., Smith, G., Conn, C. A. and Smith, F.: Local9 o/ r) X+ x' U8 v
androgenic effect of interstitial cell tumor of the testis. J.
& X5 e" }9 w& z- z7 g4 {7 E- @; \$ P* kUrol., 104: 774, 1970.
& c1 q2 {8 i% Y) |4 w9 D; A7. Schonfeld, W. A. and Beebe, G. W.: Normal growth and varia-
! L: A1 @, D% ?$ Y7 m# z1 V1 Dtion in the male genitalia from birth to maturity. J. Urol., 48:
您需要登錄後才可以回帖 登錄 | 立即注册

本版積分規則


快速回復 返回頂部 返回列表